BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2013
View Archived Issues
Researchers discover novel urinary biomarker of membranous nephropathy
Read More
Investigators present preclinical data for (+)-[18F]flubatine
Read More
Tigatuzumab evaluated in patients with triple-negative breast cancer
Read More
First-in-human data for SYK inhibitor P505-15
Read More
Faldaprevir/BI-207127/ribavirin HCV treatment regimen analyzed in phase II trial
Read More
Novel PKB/c-Akt inhibitors synthesized by Array BioPharma and Genentech
Read More
Biosortia collaborates to discover natural products for infectious disease
Read More
Sea Lane grants Takeda access to ConCIRT libraries for use in drug discovery
Read More
First patient enrolled in global phase IIb study of rostafuroxin
Read More
Ataluren demonstrates sustained effects over time in patients with nmCF
Read More
Amrita Therapeutics discloses novel antiviral proteins
Read More
Nerviano Medical Sciences presents new PARP inhibitors
Read More
New PKC-iota inhibitors synthesized at Cancer Research Technology and Cephalon
Read More
Verastem receives orphan medicinal product designation in Europe for VS-6063
Read More
Omeros cleared to begin phase I trial of OMS-721
Read More
Bionor Pharma completes first part of phase II study combining Vacc-4x with Revlimid
Read More
Epizyme enrolls first patient in phase I/II trial of EPZ-6438
Read More
Northwest Biotherapeutics begins phase I/II trial of DCVax-Direct in solid tumors
Read More
Lilly's BACC study in Alzheimer's disease terminated
Read More
Xoma begins pilot trial of gevokizumab in patients with pyoderma gangrenosum
Read More
Safety monitoring board recommends continuation of VALOR trial
Read More
FDA approves Xgeva to treat giant cell tumor of bone
Read More
Cangene withdraws IB-1001 MAA, plans to resubmit
Read More
Astellas launches Xtandi in Canada for castration-resistant prostate cancer
Read More
First phase II results of novel cPLA2 inhibitor for rheumatoid arthritis
Read More